A US judge has said Teva Pharmaceuticals did not infringe patents belonging to a rival company after seeking approval to market a generic version of the drug.
IP law firm Sterne Kessler Goldstein & Fox PLLC has announced the election of three new directors to its life sciences team.
The US Supreme Court has refused to hear the Organic Seed Growers and Trade Association’s case against Monsanto, along with two other patent cases as revealed in a document released on January 13.
On January 10, the US Supreme Court agreed to decide on so-called ambiguous patent claims in Nautilus v Biosig Instruments.
General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.
Biopharmaceutical company Alnylam has paid Merck $175 million for its subsidiary Sirna Therapeutics, a firm specialising in RNA interference therapeutics.
Edwards Wildman Palmer LLP has hired Edward Glynn, a former senior official at the Federal Trade Commission.
Anishiya Abrol, a life sciences IP specialist, has been promoted to counsel at law firm Hogan Lovells.
EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Enzo Biochem, a US biotechnology company, has received another $12.4 million from a patent ruling against Applera Corp, bringing the total damages sum to around $61 million.